AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Qrasvilda M 500mg/50mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Q'RAS Pharmaceuticals

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Qrasvilda M 500mg/50mg Tablet ER

Diabex Duo 500mg/50mg Extended-Release tablets combine two medications to manage elevated blood glucose in patients with type 2 diabetes. This dual action helps prevent serious diabetic complications like nephropathy and retinopathy, and may lessen the risk of cardiovascular events. Diabex Duo may be prescribed alone or in conjunction with other antidiabetic therapies. Optimal efficacy requires adherence to a physician-recommended diet and exercise regimen. Dosage is individualized based on your health status, blood glucose readings, and other medications. Consuming it with food minimizes gastrointestinal upset. Consistent daily dosing at the same time maximizes therapeutic benefit; discontinue only under medical supervision. Effective blood sugar control reduces the risk of future complications. Maintaining your prescribed diet and exercise plan is crucial for overall diabetes management; lifestyle significantly impacts disease control. Common adverse reactions include diarrhea, nausea, vomiting, dyspepsia, headache, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential side effect, particularly when used with insulin or sulfonylureas; learn its recognition and management. This medication isn't suitable for all individuals. Prior to initiating treatment, disclose any history of kidney, liver, or heart disease, pancreatic disorders, or significant alcohol consumption. Pregnant or lactating individuals should seek medical advice before use. Inform your doctor of all other medications to ensure safe interaction. Alcohol should be limited due to its potential to lower blood glucose. Your physician will monitor kidney function and blood sugar levels throughout treatment.

Uses of Qrasvilda M 500mg/50mg Tablet ER

Managing type 2 diabetes

Major Benefits of Qrasvilda M 500mg/50mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Qrasvilda M 500mg/50mg Extended-Release tablet whole; avoid chewing, crushing, or fracturing. Consume with food.

Common Side effects of Qrasvilda M 500mg/50mg Tablet ER:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Qrasvilda M 500mg/50mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Qrasvilda M 500mg/50mg Extended-Release tablet whole; do not break, crush, or chew it. Administer this medication with food.

How Qrasvilda M 500mg/50mg Tablet ER works:

Extended-release Qrasvilda M tablets (500mg/50mg) contain a dual antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Qrasvilda M 500mg/50mg Extended-Release Tablets with alcohol is dangerous.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Qrasvilda M 500mg/50mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Qrasvilda M 500mg/50mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when using Qrasvilda M 500mg/50mg Extended-Release tablets. Dosage modification of Qrasvilda M 500mg/50mg Extended-Release tablets may be necessary. Physician consultation is advised.

LiverLiverUNSAFE

Extended-release Qrasvilda M 500mg/50mg tablets are likely contraindicated for individuals with hepatic impairment and should be omitted. Medical advice is recommended.

What if you forget to take Qrasvilda M 500mg/50mg Tablet ER :

Should you forget a dose of Qrasvilda M 500mg/50mg Extended-Release Tablet, take it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual regimen. Avoid taking a double dose.

Facts to Know About Qrasvilda M 500mg/50mg Tablet ER

LabelValue
Developing Habits No.
Type of Treatment Diabetes Management

FAQs on Qrasvilda M 500mg/50mg Tablet ER

Qrasvilda M 500mg/50mg Tablet ER rarely causes hypoglycemia by itself. However, low blood sugar can result from inadequate caloric intake while using this medication. Symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, and shakiness may indicate hypoglycemia, particularly if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Regular blood sugar monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is advised.
Nausea and vomiting are possible side effects of Qrasvilda M 500mg/50mg Tablet ER. If vomiting occurs, sip small amounts of water or other fluids frequently. Persistent vomiting or signs of dehydration (dark, strong-smelling urine, infrequent urination) warrant immediate medical attention. Consult your doctor before taking any other medication.
Qrasvilda M 500mg/50mg Tablet ER is contraindicated in patients with allergies to its components or excipients. It should also not be used by individuals with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Qrasvilda M 500mg/50mg Extended-Release tablets combine metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Qrasvilda M 500mg/50mg Tablet ER can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Qrasvilda M 500mg/50mg Tablet ER and seek immediate medical attention.
Prolonged use of Qrasvilda M 500mg/50mg Tablet ER can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left unaddressed, may result in anemia and neurological complications.
Using Qrasvilda M 500mg/50mg Tablet ER as directed by your doctor is safe. However, even with correct dosage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and low blood sugar (especially if using insulin or sulphonylurea) may occur. Report any persistent issues to your doctor.
Qrasvilda M 500mg/50mg Ta...
107
MRP 130
17% off